Corpus Intelligence IC Memo — FERRY COUNTY MEMORIAL HOSPITAL 2026-04-26 10:39 UTC
IC Memo — FERRY COUNTY MEMORIAL HOSPITAL
Investment Committee Memorandum | WA | 25 beds | Grade D | EBITDA uplift $1.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FERRY COUNTY MEMORIAL HOSPITAL

CCN 501322 | FERRY, WA | 25 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

FERRY COUNTY MEMORIAL HOSPITAL is a 25-bed safety-net/medicaid heavy in FERRY, WA with $16.6M in net patient revenue and a -5.3% operating margin. The hospital serves a payer mix of 23.8% Medicare, 55.8% Medicaid, and 20.4% commercial.

Thesis: Turnaround. Our ML models identify $1.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.3% to 2.0% (+736bps).

Net Revenue HCRIS$16.6M
Current EBITDA COMPUTED$-885K
Operating Margin COMPUTED-5.3%
Occupancy HCRIS48.3%
Revenue / Bed COMPUTED$664K
Net-to-Gross HCRIS59.4%
Distress Probability ML64.7%

2. Market Context & Competitive Position

104
WA Hospitals
-10.3%
State Median Margin
42
Comparable Hospitals

WA has 104 Medicare-certified hospitals with a median operating margin of -10.3%. The target's margin of -5.3% places it above the state median. Among 42 size-comparable peers (12-50 beds), the median margin is -9.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 42 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FERRY COUNTY MEMORIAL HOSPITAL (Target)WA25$16.6M-5.3%
FRED HUTCHINSON CANCER CENTERWA20$1.17B-50.0%
JEFFERSON GENERAL HOSPITALWA25$148.0M-3.0%
SAMARITAN HOSPITALWA48$137.4M-4.1%
MASON GENERAL HOSPITALWA25$127.1M-5.3%
KITTITAS VALLEY COMMUNITY HOSPWA25$121.0M2.3%
TRI-STATE MEMORIAL HOSPITALWA25$107.0M0.8%
ISLAND HOSPITALWA43$106.1M-15.0%
ASTRIA SUNNYSIDE HOSPITALWA25$102.5M1.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$349K+210bp18mo
Cost to Collect4.5%2.5%$332K+200bp12mo
Denial Rate Reduction12.0%6.5%$329K+198bp12mo
A/R Days Reduction5200.0%3800.0%$202K+122bp9mo
Clean Claim Rate88.0%96.0%$11K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$349K
Cost to Collect
$332K
Denial Rate Reduction
$329K
A/R Days Reduction
$202K
Clean Claim Rate
$11K
Total EBITDA Uplift$1.2M
Current EBITDA$-885K
+ RCM Uplift+$1.2M
Pro Forma EBITDA$337K
Current Margin-5.3%
Pro Forma Margin2.0%
WC Released (1x)$637K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.4M$6.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.4M$6.6M0.00x-100.0%
Bull Case9.0x11.0x$-1.2M$10.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.2M$10.7M0.00x-100.0%
Bear Case11.0x10.0x$-1.5M$713K0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.5M$298K0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (55.8%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 64.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 42 hospitals with 12-50 beds
  • Same-state prioritization (n=43)
  • Comp margins: P25=-15.9% / P50=-9.5% / P75=-4.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.